Encephalopathy associated with ifosphamide/mesna therapy.
Meanwell
C A
CA
Blake
A E
AE
Latief
T N
TN
Blackledge
G
G
Mould
J J
JJ
Blake
D R
DR
Shaw
I C
IC
Honigsberger
L
L
Spooner
D
D
Williams
A C
AC
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001927:Brain Diseases / Q000139:chemically induced*; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D008623:Mercaptoethanol / Q000031:analogs & derivatives*; D015080:Mesna / Q000009:adverse effects*; D014594:Uterine Neoplasms / Q000188:drug therapy
D008623:Mercaptoethanol; D003520:Cyclophosphamide; D015080:Mesna; D007069:Ifosfamide